Biomarin Pharmaceutical Inc (BMRN) Insider Ownership

Historic Insider Ownership Trends

BMRN's three largest insider shareholders as of April 17, 2026 are Jean Jacques Bienaime (Chief Executive Officer, 473.79K shares), Jean Jacques Bienaime (Chief Executive Officer, 247.43K shares), Alexander Hardy (Chief Executive Officer, 214.63K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Jean Jacques Bienaime Chief Executive Officer 473,792 0 21 May, 2024
Jean Jacques Bienaime Chief Executive Officer 0 247,433 14 Feb, 2023
Alexander Hardy Chief Executive Officer 214,635 0 19 Mar, 2026
Henry J Fuchs President, Worldwide Rd 185,074 0 17 Sep, 2024
Richard A Meier - 127,426 0 22 May, 2025
Brian Mueller Evp, Chief Financial Officer 123,314 0 19 Mar, 2026
Charles Greg Guyer Evp, Chief Technical Officer 84,140 0 19 Mar, 2026
George Eric Davis Evp, Chief Legal Officer 78,560 0 19 Mar, 2026
Jeffrey Robert Ajer Evp, Chief Commercial Officer 66,767 0 06 May, 2024
Gregory R Friberg Evp, Chief Rd Officer 55,099 0 18 Mar, 2026
David E I Pyott - 49,750 0 23 May, 2024
Cristin Hubbard Evp, Chief Commercial Officer 44,790 0 18 Mar, 2026
Robert J. Hombach - 41,870 0 22 May, 2025
Willard H Dere - 38,950 0 22 May, 2025
Elizabeth M Anderson - 34,450 0 22 May, 2025
V Bryan Lawlis - 33,140 0 24 May, 2023
Dennis Slamon - 31,299 0 20 Mar, 2024
Maykin Ho - 28,010 0 22 May, 2025
Rashmi Virendra Ramchandani Vp, Chief Accounting Officer 25,610 0 22 Jan, 2026
Mark J Alles - 15,095 0 24 May, 2023
Erin Burkhart Gvp, Chief Accounting Officer 14,173 0 20 May, 2025
Barbara W. Bodem - 13,555 0 22 May, 2025
Mark J Enyedy - 13,550 0 22 May, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
17 Mar, 2026 Brian Mueller Common Stock D 2,117 $56.05 123,314 D F
18 Mar, 2026 George Eric Davis Common Stock D 1,273 $56.05 78,560 D F
17 Mar, 2026 Alexander Hardy Common Stock D 4,252 $56.05 214,635 D F
17 Mar, 2026 Charles Greg Guyer Common Stock D 1,693 $56.05 84,140 D F
16 Mar, 2026 Cristin Hubbard Common Stock A 15,410 $0.00 46,035 D A
16 Mar, 2026 Gregory R Friberg Common Stock A 19,150 $0.00 56,728 D A
17 Mar, 2026 Cristin Hubbard Common Stock D 1,245 $56.05 44,790 D F
17 Mar, 2026 Gregory R Friberg Common Stock D 1,629 $56.05 55,099 D F
16 Mar, 2026 Gregory R Friberg Stock Option (Right to Buy Common Stock) A 45,600 $0.00 45,600 D A
16 Mar, 2026 Cristin Hubbard Stock Option (Right to Buy Common Stock) A 36,680 $0.00 36,680 D A
16 Mar, 2026 George Eric Davis Common Stock D 7,177 $58.51 65,263 D F
13 Mar, 2026 Alexander Hardy Common Stock D 2,941 $58.51 156,447 D F
13 Mar, 2026 Brian Mueller Common Stock D 9,945 $58.51 106,691 D F
13 Mar, 2026 Charles Greg Guyer Common Stock D 9,109 $58.51 70,843 D F
16 Mar, 2026 Charles Greg Guyer Common Stock A 14,990 $0.00 85,833 D A
16 Mar, 2026 George Eric Davis Common Stock A 14,570 $0.00 79,833 D A
16 Mar, 2026 Brian Mueller Common Stock A 18,740 $0.00 125,431 D A
16 Mar, 2026 Alexander Hardy Common Stock A 62,440 $0.00 218,887 D A
16 Mar, 2026 George Eric Davis Stock Option (Right to Buy Common Stock) A 34,690 $0.00 34,690 D A
16 Mar, 2026 Brian Mueller Stock Option (Right to Buy Common Stock) A 44,600 $0.00 44,600 D A